elbasvir-grazoprevir drug combination
(SVPWXLXHFSKQRN-QZUDGTEMSA-N)
Structure
- SMILES
- COC(=O)N[C@H](C(=O)N1CCC[C@@H]1C1N=CC(=N1)c1ccc2c(c1)O[C@H](n1c2cc2c1ccc(c2)c1cnc([nH]1)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)OC)c1ccccc1)C(C)C.C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@@H](NC(=O)O[C@@H]1C[C@H]1CCCCCc1c(O2)nc2cc(OC)ccc2n1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1
- Molecular Formula:
- C87H105N15O16S
- Molecular Weight:
- 1648.920
- Log P:
- 12.2130
- Hydrogen Bond Acceptor:
- 30
- Hydrogen Bond Donor:
- 6
- TPSA:
- 388.44
- CAS Number(s):
- N/A
Synonym(s)
1.
elbasvir-grazoprevir drug combination
2.
Zepatier
3.
elbasvir grazoprevir drug combination
4.
elbasvir, grazoprevir drug combination
External Link(s)
| MeSH | C000611265 |
| PubChem Compound | 91669168 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fatigue | FAERS: 554 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 2 | Headache | FAERS: 441 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 3 | Nausea | FAERS: 244 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 4 | Drug dose omission | FAERS: 136 | US FAERS | |
| 5 | No adverse event | FAERS: 76 | US FAERS | |
| 6 | Hepatitis C | FAERS: 61 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 7 | Dizziness | FAERS: 60 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Adverse event | FAERS: 59 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 9 | Pruritus | FAERS: 51 | US FAERS | |
| 10 | Vomiting | FAERS: 47 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 11 | Constipation | FAERS: 43 | US FAERS | |
| 12 | Arthralgia | FAERS: 39 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Abdominal discomfort | FAERS: 36 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 14 | Pain | FAERS: 34 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 15 | Drug ineffective | FAERS: 32 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 16 | Memory impairment | FAERS: 28 | US FAERS | |
| 17 | Abdominal Pain | FAERS: 27 | US FAERS | |
| 18 | Dyspepsia | FAERS: 26 | US FAERS | |
| 19 | Inappropriate schedule of drug administration | FAERS: 26 | US FAERS | |
| 20 | Alopecia | FAERS: 25 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 21 | Asthenia | FAERS: 25 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 22 | Peripheral swelling | FAERS: 24 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 23 | Anxiety | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 24 | Myalgia | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 25 | Product use issue | FAERS: 22 | US FAERS | |
| 26 | Wrong technique in product usage process | FAERS: 22 | US FAERS | |
| 27 | treatment failure | FAERS: 22 Canada Vigilance: 12 | Canada Vigilance US FAERS | |
| 28 | Feeling abnormal | FAERS: 19 | US FAERS | |
| 29 | Pneumonia | FAERS: 18 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 30 | Somnolence | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 31 | Weight decreased | FAERS: 18 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 32 | Back Pain | FAERS: 17 | US FAERS | |
| 33 | Bone pain | FAERS: 16 | US FAERS | |
| 34 | Chest Pain | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | Malaise | FAERS: 15 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 36 | Dehydration | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 37 | Chills | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Dry skin | FAERS: 12 | US FAERS | |
| 39 | Product storage error | FAERS: 12 | US FAERS | |
| 40 | Chromaturia | FAERS: 11 | US FAERS | |
| 41 | Therapy cessation | FAERS: 10 | US FAERS | |
| 42 | Urticaria | FAERS: 10 | US FAERS | |
| 43 | Accidental overdose | FAERS: 9 | US FAERS | |
| 44 | Alanine Aminotransferase Increased | FAERS: 9 | US FAERS | |
| 45 | Aspartate Aminotransferase Increased | FAERS: 9 | US FAERS | |
| 46 | Nasopharyngitis | FAERS: 9 | US FAERS | |
| 47 | Therapeutic response unexpected | FAERS: 9 | US FAERS | |
| 48 | Tremor | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 49 | Ascites | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Swelling | FAERS: 8 | US FAERS | |
| 51 | Therapy non-responder | FAERS: 8 | US FAERS | |
| 52 | Blood glucose decreased | FAERS: 7 | US FAERS | |
| 53 | Cerebrovascular accident | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 54 | Circumstance or information capable of leading to medication error | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 55 | Dysgeusia | FAERS: 7 | US FAERS | |
| 56 | Epistaxis | FAERS: 7 | US FAERS | |
| 57 | Incorrect product storage | FAERS: 7 | US FAERS | |
| 58 | Thrombocytopenia | FAERS: 7 | US FAERS | |
| 59 | Angioedema | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 60 | Blood creatinine increased | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 61 | Blood glucose increased | FAERS: 6 | US FAERS | |
| 62 | Joint swelling | FAERS: 6 | US FAERS | |
| 63 | Maternal exposure during pregnancy | FAERS: 6 | US FAERS | |
| 64 | Musculoskeletal Pain | FAERS: 6 | US FAERS | |
| 65 | Myocardial Infarction | FAERS: 6 | US FAERS | |
| 66 | Overdose | FAERS: 6 | US FAERS | |
| 67 | Psoriasis | FAERS: 6 | US FAERS | |
| 68 | Rash erythematous | FAERS: 6 | US FAERS | |
| 69 | Restless Legs Syndrome | FAERS: 6 | US FAERS | |
| 70 | Stress | FAERS: 6 | US FAERS | |
| 71 | Viral upper respiratory tract infection | FAERS: 6 | US FAERS | |
| 72 | Amnesia | FAERS: 5 | US FAERS | |
| 73 | Arthritis | FAERS: 5 | US FAERS | |
| 74 | Atrial Fibrillation | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 75 | Burning sensation | FAERS: 5 | US FAERS | |
| 76 | Drug effect incomplete | FAERS: 5 | US FAERS | |
| 77 | Flatulence | FAERS: 5 | US FAERS | |
| 78 | Hepatitis C virus test positive | FAERS: 5 | US FAERS | |
| 79 | Hypersensitivity | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 80 | Incorrect dose administered | FAERS: 5 | US FAERS | |
| 81 | Neck Pain | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 82 | Night sweats | FAERS: 5 | US FAERS | |
| 83 | Pancreatitis | FAERS: 5 | US FAERS | |
| 84 | Productive Cough | FAERS: 5 | US FAERS | |
| 85 | Renal pain | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 86 | Urinary tract infection | FAERS: 5 | US FAERS | |
| 87 | Visual Impairment | FAERS: 5 | US FAERS | |
| 88 | Bronchitis | FAERS: 4 | US FAERS | |
| 89 | Chest discomfort | FAERS: 4 | US FAERS | |
| 90 | Crying | FAERS: 4 | US FAERS | |
| 91 | Drug dispensing error | FAERS: 4 | US FAERS | |
| 92 | Extra dose administered | FAERS: 4 | US FAERS | |
| 93 | Hypersomnia | FAERS: 4 | US FAERS | |
| 94 | Infection | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 95 | Limb injury | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 96 | Mood swings | FAERS: 4 | US FAERS | |
| 97 | Muscle tightness | FAERS: 4 | US FAERS | |
| 98 | Musculoskeletal stiffness | FAERS: 4 | US FAERS | |
| 99 | Neuralgia | FAERS: 4 | US FAERS | |
| 100 | Pathogen resistance | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 101 | Poor quality sleep | FAERS: 4 | US FAERS | |
| 102 | Product availability issue | FAERS: 4 | US FAERS | |
| 103 | Product supply issue | FAERS: 4 | US FAERS | |
| 104 | Stomatitis | FAERS: 4 | US FAERS | |
| 105 | Viral load decreased | FAERS: 4 | US FAERS | |
| 106 | Acute kidney injury | FAERS: 3 | US FAERS | |
| 107 | Blood alkaline phosphatase increased | FAERS: 3 | US FAERS | |
| 108 | Blood blister | FAERS: 3 | US FAERS | |
| 109 | Blood potassium increased | FAERS: 3 | US FAERS | |
| 110 | Cholelithiasis | FAERS: 3 | US FAERS | |
| 111 | Depressed Level of Consciousness | FAERS: 3 | US FAERS | |
| 112 | Discomfort | FAERS: 3 | US FAERS | |
| 113 | Disease recurrence | FAERS: 3 | US FAERS | |
| 114 | Diverticulum | FAERS: 3 | US FAERS | |
| 115 | Drug resistance | FAERS: 3 | US FAERS | |
| 116 | Drug screen positive | FAERS: 3 | US FAERS | |
| 117 | Dysphonia | FAERS: 3 | US FAERS | |
| 118 | Erythema | FAERS: 3 | US FAERS | |
| 119 | Fluid overload | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 120 | Food craving | FAERS: 3 | US FAERS | |
| 121 | Gout | FAERS: 3 | US FAERS | |
| 122 | Hepatitis | FAERS: 3 | US FAERS | |
| 123 | Incorrect route of drug administration | FAERS: 3 | US FAERS | |
| 124 | Intentional product misuse | FAERS: 3 | US FAERS | |
| 125 | Intestinal Obstruction | FAERS: 3 | US FAERS | |
| 126 | Myositis | FAERS: 3 | US FAERS | |
| 127 | Product difficult to swallow | FAERS: 3 | US FAERS | |
| 128 | Product dose omission | FAERS: 3 Canada Vigilance: 14 | Canada Vigilance US FAERS | |
| 129 | Product quality issue | FAERS: 3 | US FAERS | |
| 130 | Product use complaint | FAERS: 3 | US FAERS | |
| 131 | Pulmonary Embolism | FAERS: 3 | US FAERS | |
| 132 | Retching | FAERS: 3 | US FAERS | |
| 133 | Sepsis | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 134 | Tension Headache | FAERS: 3 | US FAERS | |
| 135 | Thirst | FAERS: 3 | US FAERS | |
| 136 | Thrombosis | FAERS: 3 | US FAERS | |
| 137 | Viral load increased | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 138 | Acne | FAERS: 2 | US FAERS | |
| 139 | Alcohol abuse | FAERS: 2 | US FAERS | |
| 140 | Application site erythema | FAERS: 2 | US FAERS | |
| 141 | Application site irritation | FAERS: 2 | US FAERS | |
| 142 | Arthropathy | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 143 | Asthenopia | FAERS: 2 | US FAERS | |
| 144 | Back disorder | FAERS: 2 | US FAERS | |
| 145 | Blood creatine phosphokinase increased | FAERS: 2 | US FAERS | |
| 146 | Blood sodium decreased | FAERS: 2 | US FAERS | |
| 147 | Cardiac Arrest | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 148 | Cataract | FAERS: 2 | US FAERS | |
| 149 | Choking | FAERS: 2 | US FAERS | |
| 150 | Cold sweat | FAERS: 2 | US FAERS | |
| 151 | Drug administration error | FAERS: 2 | US FAERS | |
| 152 | Drug level increased | FAERS: 2 | US FAERS | |
| 153 | Drug withdrawal syndrome | FAERS: 2 | US FAERS | |
| 154 | Dysuria | FAERS: 2 | US FAERS | |
| 155 | Economic problem | FAERS: 2 | US FAERS | |
| 156 | Emotional disorder | FAERS: 2 | US FAERS | |
| 157 | Enzyme level increased | FAERS: 2 | US FAERS | |
| 158 | Epilepsy | FAERS: 2 | US FAERS | |
| 159 | Eructation | FAERS: 2 | US FAERS | |
| 160 | Eye irritation | FAERS: 2 | US FAERS | |
| 161 | Facial paralysis | FAERS: 2 | US FAERS | |
| 162 | Feeling of body temperature change | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 163 | Gastric ulcer | FAERS: 2 | US FAERS | |
| 164 | Guillain-Barre Syndrome | FAERS: 2 | US FAERS | |
| 165 | Head Banging | FAERS: 2 | US FAERS | |
| 166 | Hepatitis B | FAERS: 2 | US FAERS | |
| 167 | Hypophagia | FAERS: 2 | US FAERS | |
| 168 | Hypoxia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 169 | Impaired work ability | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 170 | Infarction | FAERS: 2 | US FAERS | |
| 171 | Influenza | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 172 | Lethargy | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 173 | Lip swelling | FAERS: 2 | US FAERS | |
| 174 | Loss of personal independence in daily activities | FAERS: 2 | US FAERS | |
| 175 | Lymphoma | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 176 | Medication residue present | FAERS: 2 | US FAERS | |
| 177 | Mental impairment | FAERS: 2 | US FAERS | |
| 178 | Middle insomnia | FAERS: 2 | US FAERS | |
| 179 | Muscle strain | FAERS: 2 | US FAERS | |
| 180 | Nephrolithiasis | FAERS: 2 | US FAERS | |
| 181 | Neutropenia | FAERS: 2 | US FAERS | |
| 182 | Nocturia | FAERS: 2 | US FAERS | |
| 183 | Oropharyngeal pain | FAERS: 2 | US FAERS | |
| 184 | Platelet count abnormal | FAERS: 2 | US FAERS | |
| 185 | Polyuria | FAERS: 2 | US FAERS | |
| 186 | Product dosage form issue | FAERS: 2 | US FAERS | |
| 187 | Product packaging quantity issue | FAERS: 2 | US FAERS | |
| 188 | Product size issue | FAERS: 2 | US FAERS | |
| 189 | Psychomotor skills impaired | FAERS: 2 | US FAERS | |
| 190 | Respiratory Failure | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 191 | Restlessness | FAERS: 2 | US FAERS | |
| 192 | Rheumatoid Arthritis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 193 | Schizophrenia | FAERS: 2 | US FAERS | |
| 194 | Septic Shock | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 195 | Sluggishness | FAERS: 2 | US FAERS | |
| 196 | Stevens-Johnson Syndrome | FAERS: 2 | US FAERS | |
| 197 | Tachycardia | FAERS: 2 | US FAERS | |
| 198 | Therapy change | FAERS: 2 | US FAERS | |
| 199 | Trichorrhexis | FAERS: 2 | US FAERS | |
| 200 | Urinary Retention | FAERS: 2 | US FAERS | |
| 201 | Vertigo | FAERS: 2 | US FAERS | |
| 202 | Abstains from alcohol | FAERS: 1 | US FAERS | |
| 203 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 204 | Acute myocardial infarction | FAERS: 1 | US FAERS | |
| 205 | Agitation | FAERS: 1 | US FAERS | |
| 206 | Alcohol Use Disorder | FAERS: 1 | US FAERS | |
| 207 | Alcohol withdrawal syndrome | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 208 | Alopecia totalis | FAERS: 1 | US FAERS | |
| 209 | Amphetamines positive | FAERS: 1 | US FAERS | |
| 210 | Anger | FAERS: 1 | US FAERS | |
| 211 | Ankle Fracture | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 212 | Application site reaction | FAERS: 1 | US FAERS | |
| 213 | Asthma | FAERS: 1 | US FAERS | |
| 214 | Ataxia | FAERS: 1 | US FAERS | |
| 215 | Atrial Flutter | FAERS: 1 | US FAERS | |
| 216 | Atypical pneumonia | FAERS: 1 | US FAERS | |
| 217 | Bedridden | FAERS: 1 | US FAERS | |
| 218 | Bilirubin conjugated increased | FAERS: 1 | US FAERS | |
| 219 | Blindness | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 220 | Blood HIV RNA below assay limit | FAERS: 1 | US FAERS | |
| 221 | Blood albumin decreased | FAERS: 1 | US FAERS | |
| 222 | Blood alcohol increased | FAERS: 1 | US FAERS | |
| 223 | Blood bilirubin unconjugated increased | FAERS: 1 | US FAERS | |
| 224 | Blood cholesterol increased | FAERS: 1 | US FAERS | |
| 225 | Blood count abnormal | FAERS: 1 | US FAERS | |
| 226 | Blood creatine abnormal | FAERS: 1 | US FAERS | |
| 227 | Blood creatine decreased | FAERS: 1 | US FAERS | |
| 228 | Blood glucose abnormal | FAERS: 1 | US FAERS | |
| 229 | Blood potassium abnormal | FAERS: 1 | US FAERS | |
| 230 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 231 | Blood sodium abnormal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 232 | Blood triglycerides increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 233 | Blood urea increased | FAERS: 1 | US FAERS | |
| 234 | Blood urine present | FAERS: 1 | US FAERS | |
| 235 | Bowel movement irregularity | FAERS: 1 | US FAERS | |
| 236 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 237 | Cardiovascular insufficiency | FAERS: 1 | US FAERS | |
| 238 | Cellulitis | FAERS: 1 | US FAERS | |
| 239 | Cerebral disorder | FAERS: 1 | US FAERS | |
| 240 | Cluster Headache | FAERS: 1 | US FAERS | |
| 241 | Colectomy | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 242 | Creatinine renal clearance increased | FAERS: 1 | US FAERS | |
| 243 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 244 | Delirium | FAERS: 1 | US FAERS | |
| 245 | Dementia | FAERS: 1 | US FAERS | |
| 246 | Dental caries | FAERS: 1 | US FAERS | |
| 247 | Dependence | FAERS: 1 | US FAERS | |
| 248 | Depressed mood | FAERS: 1 | US FAERS | |
| 249 | Diabetes Mellitus | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 250 | Diplopia | FAERS: 1 | US FAERS | |
| 251 | Disease Progression | FAERS: 1 | US FAERS | |
| 252 | Disorientation | FAERS: 1 | US FAERS | |
| 253 | Diverticulitis | FAERS: 1 | US FAERS | |
| 254 | Drug abuse | FAERS: 1 | US FAERS | |
| 255 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 256 | Drug screen false positive | FAERS: 1 | US FAERS | |
| 257 | Dysarthria | FAERS: 1 | US FAERS | |
| 258 | Epicondylitis | FAERS: 1 | US FAERS | |
| 259 | Excoriation | FAERS: 1 | US FAERS | |
| 260 | Exfoliative rash | FAERS: 1 | US FAERS | |
| 261 | Expired product administered | FAERS: 1 | US FAERS | |
| 262 | Exposure via body fluid | FAERS: 1 | US FAERS | |
| 263 | Exposure via father | FAERS: 1 | US FAERS | |
| 264 | Eye allergy | FAERS: 1 | US FAERS | |
| 265 | Eye pain | FAERS: 1 | US FAERS | |
| 266 | Facial Pain | FAERS: 1 | US FAERS | |
| 267 | Feeling Cold | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 268 | Flank Pain | FAERS: 1 | US FAERS | |
| 269 | Food aversion | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 270 | Full blood count abnormal | FAERS: 1 | US FAERS | |
| 271 | Gait inability | FAERS: 1 | US FAERS | |
| 272 | Gamma-Glutamyltransferase Increased | FAERS: 1 | US FAERS | |
| 273 | Gangrene | FAERS: 1 | US FAERS | |
| 274 | Gastritis | FAERS: 1 | US FAERS | |
| 275 | Gastrointestinal infection | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 276 | Gene Mutation | FAERS: 1 | US FAERS | |
| 277 | Gene mutation identification test positive | FAERS: 1 | US FAERS | |
| 278 | Genotype drug resistance test positive | FAERS: 1 | US FAERS | |
| 279 | Head discomfort | FAERS: 1 | US FAERS | |
| 280 | Heavy exposure to ultraviolet light | FAERS: 1 | US FAERS | |
| 281 | Hepatitis C RNA fluctuation | FAERS: 1 | US FAERS | |
| 282 | Hepatitis C RNA increased | FAERS: 1 | US FAERS | |
| 283 | Hernia | FAERS: 1 | US FAERS | |
| 284 | Herpes simplex meningitis | FAERS: 1 | US FAERS | |
| 285 | Hypotension | FAERS: 1 | US FAERS | |
| 286 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 287 | Impaired quality of life | FAERS: 1 | US FAERS | |
| 288 | Inappropriate schedule of product administration | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 289 | Incontinence | FAERS: 1 | US FAERS | |
| 290 | Incorrect drug administration duration | FAERS: 1 | US FAERS | |
| 291 | Increased upper airway secretion | FAERS: 1 | US FAERS | |
| 292 | Infected cyst | FAERS: 1 | US FAERS | |
| 293 | Inflammation | FAERS: 1 | US FAERS | |
| 294 | Infrequent bowel movements | FAERS: 1 | US FAERS | |
| 295 | Insurance issue | FAERS: 1 | US FAERS | |
| 296 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 297 | Joint injury | FAERS: 1 | US FAERS | |
| 298 | Joint stiffness | FAERS: 1 | US FAERS | |
| 299 | Laceration | FAERS: 1 | US FAERS | |
| 300 | Laryngitis | FAERS: 1 | US FAERS | |
| 301 | Leukocytosis | FAERS: 1 | US FAERS | |
| 302 | Leukopenia | FAERS: 1 | US FAERS | |
| 303 | Loose tooth | FAERS: 1 | US FAERS | |
| 304 | Lower respiratory tract infection | FAERS: 1 | US FAERS | |
| 305 | Macule | FAERS: 1 | US FAERS | |
| 306 | Mass excision | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 307 | Migraine with Aura | FAERS: 1 | US FAERS | |
| 308 | Model for end stage liver disease score abnormal | FAERS: 1 | US FAERS | |
| 309 | Multiple allergies | FAERS: 1 | US FAERS | |
| 310 | Musculoskeletal chest pain | FAERS: 1 | US FAERS | |
| 311 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 312 | Mydriasis | FAERS: 1 | US FAERS | |
| 313 | Nephritis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 314 | Nipple pain | FAERS: 1 | US FAERS | |
| 315 | Ocular icterus | FAERS: 1 | US FAERS | |
| 316 | Oral candidiasis | FAERS: 1 | US FAERS | |
| 317 | Ototoxicity | FAERS: 1 | US FAERS | |
| 318 | Oxygen saturation abnormal | FAERS: 1 | US FAERS | |
| 319 | Pain of skin | FAERS: 1 | US FAERS | |
| 320 | Pallor | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 321 | Papule | FAERS: 1 | US FAERS | |
| 322 | Perforated ulcer | FAERS: 1 | US FAERS | |
| 323 | Peripheral artery dissection | FAERS: 1 | US FAERS | |
| 324 | Peritonsillar Abscess | FAERS: 1 | US FAERS | |
| 325 | Photophobia | FAERS: 1 | US FAERS | |
| 326 | Pneumoperitoneum | FAERS: 1 | US FAERS | |
| 327 | Poisoning | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 328 | Polydipsia | FAERS: 1 | US FAERS | |
| 329 | Polyneuropathy | FAERS: 1 | US FAERS | |
| 330 | Portal Vein Thrombosis | FAERS: 1 | US FAERS | |
| 331 | Post procedural infection | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 332 | Pregnancy test positive | FAERS: 1 | US FAERS | |
| 333 | Procedural complication | FAERS: 1 | US FAERS | |
| 334 | Product blister packaging issue | FAERS: 1 | US FAERS | |
| 335 | Product dispensing error | FAERS: 1 | US FAERS | |
| 336 | Product distribution issue | FAERS: 1 | US FAERS | |
| 337 | Product packaging confusion | FAERS: 1 | US FAERS | |
| 338 | Product packaging issue | FAERS: 1 | US FAERS | |
| 339 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 340 | Pruritus allergic | FAERS: 1 | US FAERS | |
| 341 | Pulmonary thrombosis | FAERS: 1 | US FAERS | |
| 342 | Renal cyst | FAERS: 1 | US FAERS | |
| 343 | Renal transplant failure | FAERS: 1 | US FAERS | |
| 344 | Respiratory tract congestion | FAERS: 1 | US FAERS | |
| 345 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 346 | Schizoaffective Disorder | FAERS: 1 | US FAERS | |
| 347 | Septic arthritis staphylococcal | FAERS: 1 | US FAERS | |
| 348 | Sinusitis | FAERS: 1 | US FAERS | |
| 349 | Skin Ulcer | FAERS: 1 | US FAERS | |
| 350 | Skin irritation | FAERS: 1 | US FAERS | |
| 351 | Skin lesion | FAERS: 1 | US FAERS | |
| 352 | Sneezing | FAERS: 1 | US FAERS | |
| 353 | Splenic vein thrombosis | FAERS: 1 | US FAERS | |
| 354 | Spontaneous penile erection | FAERS: 1 | US FAERS | |
| 355 | Squamous cell carcinoma | FAERS: 1 | US FAERS | |
| 356 | Strangulated hernia | FAERS: 1 | US FAERS | |
| 357 | Sunburn | FAERS: 1 | US FAERS | |
| 358 | Sustained viral response | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 359 | Syncope | FAERS: 1 | US FAERS | |
| 360 | Thermal burn | FAERS: 1 | US FAERS | |
| 361 | Tinnitus | FAERS: 1 | US FAERS | |
| 362 | Tooth Extraction | FAERS: 1 | US FAERS | |
| 363 | Tooth Infection | FAERS: 1 | US FAERS | |
| 364 | Tooth Loss | FAERS: 1 | US FAERS | |
| 365 | Toothache | FAERS: 1 | US FAERS | |
| 366 | Transaminases increased | FAERS: 1 | US FAERS | |
| 367 | Trigeminal Neuralgia | FAERS: 1 | US FAERS | |
| 368 | Tuberculosis | FAERS: 1 | US FAERS | |
| 369 | Unevaluable event | FAERS: 1 | US FAERS | |
| 370 | Unresponsive to stimuli | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 371 | Vascular resistance systemic decreased | FAERS: 1 | US FAERS | |
| 372 | Vasculitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 373 | Viral load undetectable | FAERS: 1 | US FAERS | |
| 374 | Viral mutation identified | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 375 | Viral test negative | FAERS: 1 | US FAERS | |
| 376 | Virologic failure | FAERS: 1 | US FAERS | |
| 377 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 378 | Wrong patient received medication | FAERS: 1 | US FAERS | |
| 379 | furuncle | FAERS: 1 | US FAERS | |
| 380 | jaundice | FAERS: 1 | US FAERS | |
| 381 | nervous system disorder | FAERS: 1 | US FAERS | |
| 382 | Alanine aminotransferase abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 383 | Aspartate aminotransferase abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 384 | Drug Dependence | Canada Vigilance: 1 | Canada Vigilance | |
| 385 | Food Poisoning | Canada Vigilance: 1 | Canada Vigilance | |
| 386 | Increased tendency to bruise | Canada Vigilance: 1 | Canada Vigilance | |
| 387 | Intestinal Perforation | Canada Vigilance: 1 | Canada Vigilance | |
| 388 | Porphyria non-acute | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.